Skip to main content
Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
129.93
+1.80 (1.40%)
At close: Mar 9, 2026, 4:00 PM EDT
130.02
+0.09 (0.07%)
After-hours: Mar 9, 2026, 5:56 PM EDT

Neurocrine Biosciences Revenue

In the year 2025, Neurocrine Biosciences had annual revenue of $2.86B with 21.45% growth. Neurocrine Biosciences had revenue of $805.50M in the quarter ending December 31, 2025, with 28.33% growth.

Revenue (ttm)
$2.86B
Revenue Growth
+21.45%
P/S Ratio
4.54
Revenue / Employee
$1,430,250
Employees
2,000
Market Cap
13.04B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.86B505.20M21.45%
Dec 31, 20242.36B468.20M24.81%
Dec 31, 20231.89B398.40M26.76%
Dec 31, 20221.49B355.20M31.34%
Dec 31, 20211.13B87.60M8.38%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical Industries 17.26B
Haleon 14.85B
Viatris 14.30B
Elanco Animal Health 4.72B
Dr. Reddy's Laboratories 3.85B
United Therapeutics 3.18B
Amneal Pharmaceuticals 3.02B
Hims & Hers Health 2.35B
Revenue Rankings

NBIX News

More News